- Profile
- Personal Information
- Publications
Experts in Nephrology
Jessy J. Alexander Ibrahim Batal Ann Hagan Tanya Hoodbhoy Luis Alfredo Bent-Shaw Stephen Y Nakada Wade A Bushman David F Jarrard Patrick H McKenna David R Paolone Daniel H Williams IV E. Jason Abel Jyotsna Bhatnagar Sara Best Dale E Bjorling Reginald C Bruskewitz Tracy M Downs Andrew K Graf Dan R. Gralnek Sean P Hedican View MoreMartin Olin 20 years of executive experience in the pharmaceutical and biotech industry. Before joining Symphogen, Mr. Olin was a senior partner with SLS Invest, a Scandinavian based healthcare focused private equity fund. Prior to joining SLS Invest Mr. Olin held managerial positions in Novo Nordisk including Finance Director, EMEA. Mr. Olin served on the board of Symphogen from 2001 – 2008 and joined as a Chief Financial Officer in 2012. Since September 2016, CEO of Symphogen. Mr. Olin is a Board member of Symphogen and also serves on the board of Ascendis Pharma (public company). Mr. Olin serves as a member of the Lifescience Growth Team appointed by the Danish Government in 2016..
Pharmaceutical